With the UAE health authorities granting regulatory approval to Gilead Sciences to use remdesivir in COVID-19 patients, we take a closer look at its role in the recovery process.
In an exclusive interview with Dubai Eye on One, Frederico Silva, General Manager at Gilead for the Middle East region, explains what remdesivir actually does.
He also explained at what stage a COVID-19 patient should be given the drug.
Silva also touched upon the talks Gilead is having with the UAE Ministry of Health.
Talking about the pricing, he explained how Gilead has come up with two approaches - one for less developed countries and the second for developed nations.
2 members of UAE Armed Forces martyred in helicopter crash
UAE participates in extraordinary EU–GCC leaders meeting
UAE welcomes US listing of Sudanese Muslim Brotherhood as terrorist group
UAE ambassador to UN calls for 'de-escalation' in Iran conflict
Dubai ranked world’s cleanest city for sixth consecutive year
Indian education board CBSE postpones Class 12 exams until March 16
Vietnam show support for UAE following Iran attacks
